regeneron pharmaceuticals market cap 2019

On December 31, 2019, Regeneron Pharmaceuticals (REGN) had a market capitalization of $42.7B, based on 114.32M shares at a price of $373.88.

DATE CLOSE VOLUME OUTSTANDING MARKET CAP
December 31 2019
$373.88
494,600
114,317,600
$42,740,744,198.72
December 30 2019
$372.10
369,200
114,317,600
$42,538,127,684.48
December 27 2019
$371.73
293,000
114,317,600
$42,494,869,904.64
December 26 2019
$373.26
451,900
114,317,600
$42,670,164,512.48
December 24 2019
$374.90
221,500
114,317,600
$42,857,988,329.28
December 23 2019
$372.60
431,200
114,317,600
$42,595,046,417.52
December 20 2019
$374.02
1,192,800
114,317,600
$42,756,680,072.16
December 19 2019
$370.96
903,700
114,317,600
$42,407,222,600.72
December 18 2019
$369.77
831,300
114,317,600
$42,271,767,676.48
December 17 2019
$367.52
1,002,900
114,317,600
$42,014,507,349.44
December 16 2019
$374.40
756,600
114,317,600
$42,801,069,596.24
December 13 2019
$374.81
995,900
114,317,600
$42,847,745,472.32
December 12 2019
$370.57
949,900
114,317,600
$42,362,833,076.64
December 11 2019
$371.94
935,700
114,317,600
$42,518,773,714.80
December 10 2019
$366.10
1,061,600
114,317,600
$41,851,730,518.80
December 09 2019
$364.07
974,400
114,317,600
$41,619,517,177.92
December 06 2019
$370.67
575,900
114,317,600
$42,374,207,677.84
December 05 2019
$366.77
501,800
114,317,600
$41,928,003,221.52
December 04 2019
$368.39
605,000
114,317,600
$42,113,540,686.32
December 03 2019
$367.24
929,700
114,317,600
$41,981,503,858.32
December 02 2019
$364.52
652,200
114,317,600
$41,670,742,894.48
November 29 2019
$367.42
463,600
114,317,600
$42,003,121,316.48
November 27 2019
$369.99
734,400
114,317,600
$42,296,803,230.88
November 26 2019
$362.28
735,100
114,317,600
$41,414,625,743.44
November 25 2019
$365.25
845,000
114,317,600
$41,754,983,533.92